Advertising

MAHF honors Abbate and Lazur, Future Famers

MAHF honors Abbate and Lazur, Future Famers

By

The Medical Advertising Hall of Fame recognized dozens of industry leaders and rising agency executives.

Almost one-third of programmatic ads violate IAB guidelines, study finds

Almost one-third of programmatic ads violate IAB guidelines, study finds

By

The report identifies four major issues of the 28% that were found to abuse IAB's standards.

How To Make A Doctor Happy: Take Away the Brand Message in a Drug Ad

How To Make A Doctor Happy: Take Away the Brand Message in a Drug Ad

The presumption is Dr. A saw ad B, clicked on it, went to the site and within C time, prescribed product D.

Five things for pharma marketers to know: Monday, February 6, 2017

Five things for pharma marketers to know: Monday, February 6, 2017

By

Novo Nordisk CEO describes 'volatile' pricing environment; Lilly to cut 200 research and development jobs; pharma opts out of Super Bowl this year

Merck campaign shows impact of shingles

Merck campaign shows impact of shingles

By

To drive the point home, the ads even feature an image of an actual case of shingles. The blistering red rash appears on-screen for several seconds.

Mike Lazur, 2017 MAHF inductee, on his medical advertising destiny

Mike Lazur, 2017 MAHF inductee, on his medical advertising destiny

By

He played a leading role during Torre Lazur's glory era as "the launch agency." Now he is being inducted into the Medical Advertising Hall of Fame.

It's Time for the Healthcare Industry to Take Advantage of Programmatic

It's Time for the Healthcare Industry to Take Advantage of Programmatic

Still, pharmaceutical marketers must remember that maintaining regulatory compliance is all-important.

Klick Health's Elliot Langerman on the Power of Persuasion

Klick Health's Elliot Langerman on the Power of Persuasion

Here are six global campaigns that make the case for persuasion.

Day 1 at JP Morgan: Pricing is top of mind for pharma CEOs

Day 1 at JP Morgan: Pricing is top of mind for pharma CEOs

By

The questions being asked about how drugs are priced are weighing heavily on pharma leaders, and they know the issue is not going away.

GSW's Erik Slangerup on Ads with Heart

GSW's Erik Slangerup on Ads with Heart

The heart is a tireless worker, beating day and night. When we're telling stories for healthcare brands, we should remember what it takes to infuse real feeling, to get people to care.

How pharma can stay compliant when using programmatic

How pharma can stay compliant when using programmatic

By

The risk of fraud is also very real, especially in an industry that already faces privacy and compliance challenges, one expert says.

Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.

Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.

By

Heather Bresch's appearance at industry summit came after she declined to attend a congressional hearing scheduled for the same day.

Five things for pharma marketers to know: Monday, November 28, 2016

Five things for pharma marketers to know: Monday, November 28, 2016

By

J&J in talks to buy Actelion; Novo Nordisk pulls ads on Breitbart News; Takeda to market Ninlaro in Europe

Pharma Marketers Using Programmatic, Consider Privacy and Measurement

Pharma Marketers Using Programmatic, Consider Privacy and Measurement

There's a reason pharma lags on the programmatic adoption curve: It's a heavily regulated industry, and there are concerns around privacy.

PulsePoint launches health vertical for programmatic advertising

PulsePoint launches health vertical for programmatic advertising

By

The programmatic advertising technology company also hired Chris Neuner as SVP and GM of digital health.

Centron's Letty Albarran Talks Ads That Get Personal

Centron's Letty Albarran Talks Ads That Get Personal

Here are six campaigns that connect with the patient on a personal level.

10 things for pharma marketers to know about Facebook and Instagram

10 things for pharma marketers to know about Facebook and Instagram

By

With about 70 million users in six million health-related groups, drugmakers have tremendous opportunity to reach key audiences on Facebook. Here's how.

Drugmakers, facing pricing criticism, sell cures in new ads

Drugmakers, facing pricing criticism, sell cures in new ads

By

With lawmakers, patients, and physicians crying foul over pricing, drugmakers are trying to shift the narrative — with mixed results. Can a new focus on storytelling help?

Sermo and Everyday Health partner in advertising-research deal

Sermo and Everyday Health partner in advertising-research deal

By

The partnership allows Sermo to expand the reach of its research initiatives and Everyday Health to scale its targeted advertising on the social platform.

Best Professional Print Campaign of 2016

Best Professional Print Campaign of 2016

By

With a product approved for both major depressive disorder and schizophrenia, the companies decided to create a campaign that provided cohesion and brand recognition across disease states.

Best TV Advertising Campaign of 2016

Best TV Advertising Campaign of 2016

By

In just six weeks, more than 50% of blood thinner Pradaxa's target audience had become aware of the Redfish campaign.

Merck's creative archive tells an industry story

Merck's creative archive tells an industry story

By

Did you know that Norman Rockwell was a medical illustrator for Merck?

30 years later, DTC's complicated past still hasn't deterred marketers

30 years later, DTC's complicated past still hasn't deterred marketers

By

Given its modern-day ubiquity, it's easy to forget that pharma DTC didn't exist until the 1980s rolled around.

Why the FDA's view of patient communication evolved over time

Why the FDA's view of patient communication evolved over time

By

The agency's ambitions were fueled in part by external criticism. The barbs that stung most sharply were ones suggesting a certain indifference on the FDA's part.

How to get more women in the C-suite, according to IPG, Unilever, and AOL

How to get more women in the C-suite, according to IPG, Unilever, and AOL

By

A new report analyzing gender parity in advertising found that men tend to endorse other men at higher rates than women. Execs share their insights about the issue.

Five things for pharma marketers to know: Friday, September 23, 2016

Five things for pharma marketers to know: Friday, September 23, 2016

By

Anthem and Cigna accuse each other of violating merger terms; Alzheimer's experimental drug fails late-stage study; study calls for new approach to eradicate global epidemics

Ogilvy's Michael Johnston on Using the Familiar in Diabetes Ads

Ogilvy's Michael Johnston on Using the Familiar in Diabetes Ads

The science behind new diabetes drugs underscores how far we've come from the days of purified pork insulin. Even so, most ads stick to traditional copy.

Five things for pharma marketers to know: Wednesday, September 14, 2016

Five things for pharma marketers to know: Wednesday, September 14, 2016

By

Patients who ask for a prescription after seeing an ad are more likely to get one; Mylan's executive pay is now under scrutiny

Sex, chocolate, and disability: What marketers can learn from Mars' Maltesers campaign

Sex, chocolate, and disability: What marketers can learn from Mars' Maltesers campaign

By

The latest TV campaign from Mars features a woman with cerebral palsy joking about her love life.

MM&M's top 5 stories in August 2016

MM&M's top 5 stories in August 2016

By

Shire hires Jennifer Aniston for a disease awareness campaign; critics argue that the direct-to-consumer ads for Opdivo are misleading, while Merck's Keytruda takes the lead in first-line cancer

OPINION

Why President Trump Won't Overhaul the FDA

Newsletters